tiprankstipranks
Beyondspring Inc (BYSI)
NASDAQ:BYSI

Beyondspring Stock Analysis & Ratings

BYSI Stock Chart & Stats

Day’s Range$1.25 - $1.34
52-Week Range$1.20 - $33.00
Previous Close$1.23
Volume222.28K
Average Volume (3M)426.30K
Market Cap$38.73M
P/E Ratio-0.8
Beta1.20
Next EarningsJun 16, 2022
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score3
EPS (TTM)-1.64


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

BYSI FAQ

What was Beyondspring’s price range in the past 12 months?
Beyondspring lowest stock price was $1.20 and its highest was $33.00 in the past 12 months.
    What is Beyondspring’s market cap?
    Beyondspring’s market cap is $38.73M.
      What is Beyondspring’s price target?
      Currently, no data Available
      What do analysts say about Beyondspring?
      Beyondspring’s analyst rating consensus is a ‘Hold. This is based on the ratings of 1 Wall Streets Analysts.
        When is Beyondspring’s upcoming earnings report date?
        Beyondspring’s upcoming earnings report date is Jun 16, 2022 which is in 29 days.
          How were Beyondspring’s earnings last quarter?
          Beyondspring released its earnings results on Apr 14, 2022. The company reported -$0.24 earnings per share for the quarter, missing the consensus estimate of -$0.23 by -$0.01.
            Is Beyondspring overvalued?
            According to Wall Street analysts Beyondspring’s price is currently Overvalued.
              Does Beyondspring pay dividends?
              Beyondspring does not currently pay dividends.
              What is Beyondspring’s EPS estimate?
              Beyondspring’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Beyondspring have?
              Beyondspring has 30,490,000 shares outstanding.
                What happened to Beyondspring’s price movement after its last earnings report?
                Beyondspring reported an EPS of -$0.24 in its last earnings report, missing expectations of -$0.23. Following the earnings report the stock price went down -9.877%.
                  Which hedge fund is a major shareholder of Beyondspring?
                  Among the largest hedge funds holding Beyondspring’s share is Discovery Capital Management, LLC. It holds Beyondspring’s shares valued at N/A.

                    ---

                    Beyondspring Stock Analysis

                    Smart Score
                    3
                    Underperform
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10
                    Price Target
                    No data currently available
                    The Beyondspring stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Beyondspring Inc

                    BeyondSpring, Inc. is a clinical stage company, which engages in the development of cancer therapies. It focuses on non-small cell lung cancer, neutropenia prevention, and plinabulin and nivolumab. The company was founded by Lan Huang and Lin Qing Jia in 2013 and is headquartered in New York, NY.

                    ---
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    NightHawk Biosciences
                    Fate Therapeutics
                    Kura Oncology

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis